Related Experiment Video
Updated: Sep 19, 2025

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
Published on: November 9, 2016
Botulinum toxin type A injections demonstrate remarkable efficacy in treating hemifacial spasm in elderly patients
Lihua Cao1, Min Bai1, Chao Li1
1Department of Geriatric Medicine, Nanjing Pukou People's Hospital Nanjing 211800, Jiangsu, China.
Objective:
To investigate the effectiveness of botulinum toxin type A (BTX-A) injections in elderly patients with hemifacial spasm (HFS).
Methods:
In this retrospective study, a total of 120 elderly patients diagnosed with HFS were recruited and divided into two groups: a research group (n=65) receiving multi-point BTX-A injections and a control group (n=55) undergoing conventional treatment. Comparative analyses were conducted to evaluate therapeutic efficacy, duration of efficacy, adverse reactions, Hamilton Anxiety Scale (HAMA) scores, and Hamilton Depression Scale (HAMD) scores between the two groups. Furthermore, factors influencing treatment outcomes in elderly HFS patients were investigated.
Results:
The research group demonstrated significantly higher overall efficacy, prolonged durations of therapeutic efficacy in grades II, III, and IV, a lower incidence of adverse reactions, and more pronounced improvements in HAMA and HAMD scores. Additionally, Cohen grading, HAMA and HAMD scores, and the treatment approach were independently correlated with treatment failure in elderly patients.
Conclusion:
Multi-point BTX-A injections are highly effective in treating HFS in elderly patients.
More Related Videos
05:50Subcutaneous Neurotrophin 4 Infusion Using Osmotic Pumps or Direct Muscular Injection Enhances Aging Rat Laryngeal Muscles
Published on: June 13, 2017
06:30Assessment of Static Graviceptive Perception in the Roll-Plane using the Subjective Visual Vertical Paradigm
Published on: April 28, 2020
Related Concept Videos
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Skeletal Muscle Relaxants: Therapeutic Uses
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...